These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 1361489

  • 61. Activin A inhibits cell-cycle progression induced by insulin-like growth factor-I in Balb/c 3T3 cells.
    Kojima I, Mogami H, Kawamura N, Shibata H.
    J Endocrinol; 1993 Apr; 137(1):99-105. PubMed ID: 8492081
    [Abstract] [Full Text] [Related]

  • 62. Differentiation-inducing and growth-inhibitory activities of erythroid differentiation factor (EDF/activin A) toward mouse erythroleukemic cells in vivo.
    Shiozaki M, Shioya S, Izawa M, Eto Y, Shibai H.
    Int J Cancer; 1990 Apr 15; 45(4):719-23. PubMed ID: 2323849
    [Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67. The influence of the total flavonoids of Hedysarum polybotry on the proliferation, cell cycle, and expressions of p21Ras and proliferating cell nuclear antigen gene in erythroleukemia cell line K562.
    Wang YL, Luo YL, Chen C, Li NL, She YL, Zhang L.
    Chin J Integr Med; 2012 May 15; 18(5):385-90. PubMed ID: 22241506
    [Abstract] [Full Text] [Related]

  • 68. Cell cycle analysis in developing cercariae of Trichobilharzia ocellata (Trematoda: Schistosomatidae).
    Haight M, Davidson D, Pasternak J.
    J Parasitol; 1977 Apr 15; 63(2):274-81. PubMed ID: 859083
    [Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70. Revisiting retinoblastoma protein phosphorylation during the mammalian cell cycle.
    Cooper S, Shayman JA.
    Cell Mol Life Sci; 2001 Apr 15; 58(4):580-95. PubMed ID: 11361093
    [Abstract] [Full Text] [Related]

  • 71. Triiodothyronine suppresses activin-induced differentiation of erythroleukemia K562 cells under hypoxic conditions.
    Yamamoto Y, Shiraishi M, Fujita M, Kojima I, Tanaka Y, Tachibana S.
    Mol Cell Biochem; 2014 Jun 15; 391(1-2):217-24. PubMed ID: 24604674
    [Abstract] [Full Text] [Related]

  • 72. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle.
    Goodrich DW, Wang NP, Qian YW, Lee EY, Lee WH.
    Cell; 1991 Oct 18; 67(2):293-302. PubMed ID: 1655277
    [Abstract] [Full Text] [Related]

  • 73. Erythroid differentiation bioassays for activin.
    Schwall RH, Lai C.
    Methods Enzymol; 1991 Oct 18; 198():340-6. PubMed ID: 1857227
    [No Abstract] [Full Text] [Related]

  • 74. The existence of activin A/erythroid differentiation factor and its inhibitor in human serum: comparison of normal and chronic renal failure sera.
    Shiozaki M, Sakai R, Tabuchi M, Shinohara M, Kosaka M, Saito S, Eto Y.
    Biochem Biophys Res Commun; 1992 Feb 28; 183(1):273-9. PubMed ID: 1543498
    [Abstract] [Full Text] [Related]

  • 75. Rb localization and phosphorylation kinetics correlate with the cellular phenotype of cultured breast adenocarcinoma cells.
    Botos J, Barhoumi R, Burghardt R, Kochevar DT.
    In Vitro Cell Dev Biol Anim; 2002 Apr 28; 38(4):235-41. PubMed ID: 12197776
    [Abstract] [Full Text] [Related]

  • 76. Effect of fagaronine on cell cycle progression of human erythroleukemia K562 cells.
    Comoë L, Carpentier Y, Desoize B, Jardillier JC.
    Leuk Res; 1988 Apr 28; 12(8):667-72. PubMed ID: 3184983
    [Abstract] [Full Text] [Related]

  • 77. Investigating the relationship between cell cycle stage and diosgenin-induced megakaryocytic differentiation of HEL cells using sedimentation field-flow fractionation.
    Cailleteau C, Micallef L, Lepage C, Cardot PJ, Beneytout JL, Liagre B, Battu S.
    Anal Bioanal Chem; 2010 Oct 28; 398(3):1273-83. PubMed ID: 20714892
    [Abstract] [Full Text] [Related]

  • 78. The influence of several anticancer agents on cell proliferation, differentiation and the cell cycle of murine erythroleukemia cells.
    Xu B.
    Am J Chin Med; 1981 Oct 28; 9(4):268-76. PubMed ID: 6964028
    [Abstract] [Full Text] [Related]

  • 79. Cell cycle effects of the anti-rheumatic agent CPH82.
    Rantapää Dahlqvist S, Landberg G, Roos G, Norberg B.
    Br J Rheumatol; 1994 Apr 28; 33(4):327-31. PubMed ID: 7908845
    [Abstract] [Full Text] [Related]

  • 80. Erratum: Activin A programs the differentiation of human TFH cells.
    Locci M, Wu JE, Arumemi F, Mikulski Z, Dahlberg C, Miller AT, Crotty S.
    Nat Immunol; 2016 Sep 20; 17(10):1235. PubMed ID: 27648551
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.